Loading
BT
Biospecifics Technologies Corp Stock: price and insider trades · United States
Biospecifics Technologies Corp: what insiders have been doing
Only a handful of insider records exist for Biospecifics Technologies Corp, the last one from 27 January 2016, too few to describe a trend. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
RevenueUS$33.1M
Net incomeUS$21.2M64.1% margin
Last declaration on 27 January 2016
Declarations2 total
15,000 sharesCommon Stock, $0.001 par valueSEC:0001062993-16-007310:0
100,000 sharesCommon Stock, $0.001 par valueSEC:0001062993-16-006987:0
2 of 2 declarations
About Biospecifics Technologies Corp
Biospecifics Technologies Corp is a company focused on the development of biopharmaceutical products. It specializes in the research and commercialization of treatments based on biological specificity technologies.
